Fortress Biotech, based in Bay Harbor Islands, Florida, specializes in novel pharmaceuticals with seven marketed products and over 25 developmental programs across oncology, rare diseases, and gene therapy. The company went public in November 2011 and has 186 employees.
FBIO has been in the news recently: Fortress Minerals Limited's share price has declined by 36% over the past three years and 25% in the last year, significantly underperforming the market. Fortress Solutions has partnered with Airspan to improve 5G network efficiency and expanded its FortressONE platform to include new offerings for MosoLabs.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
